AAAAAA
Results: 1-25/26
Authors:
IYER L
RATAIN MJ
Citation: L. Iyer et Mj. Ratain, PHARMACOGENETICS AND CANCER-CHEMOTHERAPY, European journal of cancer, 34(10), 1998, pp. 1493-1499
Authors:
QASBA PK
BOEGGEMAN E
RAMAKRISHNAN B
HIRATA J
IYER L
Citation: Pk. Qasba et al., STRUCTURAL INVESTIGATIONS OF THE STEM REGION OF BOVINE BETA-1,4-GALATOSYLTRANSFERASE, Glycobiology, 8(11), 1998, pp. 120-120
Authors:
IYER L
MORTELL MA
AZUMA R
YAMAMOTO Y
RATAIN MJ
Citation: L. Iyer et al., GLUCURONIDATION OF TAS-103 BY URIDINE-DIPHOSPHATE GLUCURONOSYLTRANSFERASE (UGT) ISOFORMS 1A1 AND 2 - POSSIBLE IMPLICATION OF TAS-103 TOXICITY IN GILBERTS-SYNDROME, Annals of oncology, 9, 1998, pp. 230-230
Authors:
HANNAH L
RAKOTOSAMIMANANA B
GANZHORN J
MITTERMEIER RA
OLIVIERI S
IYER L
RAJAOBELINA S
HOUGH J
ANDRIAMIALISOA F
BOWLES I
TILKIN G
Citation: L. Hannah et al., PARTICIPATORY PLANNING, SCIENTIFIC PRIORITIES, AND LANDSCAPE CONSERVATION IN MADAGASCAR, Environmental conservation, 25(1), 1998, pp. 30
Authors:
IYER L
RATAIN MJ
Citation: L. Iyer et Mj. Ratain, CLINICAL-PHARMACOLOGY OF CAMPTOTHECINS, Cancer chemotherapy and pharmacology, 42, 1998, pp. 31-43
Authors:
MANI S
IYER L
JANISCH L
WANG XL
FLEMING GF
SCHILSKY RL
RATAIN MJ
Citation: S. Mani et al., PHASE-I CLINICAL AND PHARMACOKINETIC STUDY OF ORAL 9-AMINOCAMPTOTHECIN (NSC-603071), Cancer chemotherapy and pharmacology, 42(1), 1998, pp. 84-87
Authors:
IYER L
KING CD
WHITINGTON PF
GREEN MD
ROY SK
TEPHLY TR
COFFMAN BL
RATAIN MJ
Citation: L. Iyer et al., GENETIC PREDISPOSITION TO THE METABOLISM OF IRINOTECAN (CPT-11) - ROLE OF URIDINE-DIPHOSPHATE GLUCURONOSYLTRANSFERASE ISOFORM 1A1 IN THE GLUCURONIDATION OF ITS ACTIVE METABOLITE (SN-38) IN HUMAN LIVER-MICROSOMES, The Journal of clinical investigation, 101(4), 1998, pp. 847-854
Authors:
IYER L
HALL D
DAS S
MORTELL M
KIM S
RAMIREZ J
DIRIENZO A
RATAIN MJ
Citation: L. Iyer et al., CORRELATION OF UGT1A1 GENOTYPE VERSUS SN-38 AND BILIRUBIN GLUCURONIDATION IN HUMAN LIVER SAMPLES, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 4-4
Authors:
RAMIREZ J
IYER L
LUSH RM
MORTELL M
FEUER JA
FIGG WD
SAUSVILLE EA
RATAIN MJ
Citation: J. Ramirez et al., IN-VITRO GLUCURONIDATION OF FLAVOPIRIDOL (NSC649890) (FLAVO) BY HUMANLIVER-MICROSOMES, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 50-50
Authors:
FAGBEMI S
RATAIN MJ
IYER L
MANI S
VOGELZANG NJ
WANG X
Citation: S. Fagbemi et al., PHASE-I AND PHARMACOKINETIC STUDY OF IRINOTECAN (CPT-11) ADMINISTEREDWITH CYCLOSPORINE-A (CSA), Clinical pharmacology and therapeutics, 63(2), 1998, pp. 107-107
Authors:
DIRIENZO A
HALL D
IYER L
RATAIN MJ
Citation: A. Dirienzo et al., 2 NEW ALLELES IN THE PROMOTER OF THE BILIRUBIN UDP-GLUCURONOSYL TRANSFERASE-1 (UGT1A1) GENE, Clinical pharmacology and therapeutics, 63(2), 1998, p.
Authors:
IYER L
SINGH U
Citation: L. Iyer et U. Singh, FUNCTIONAL-PROPERTIES OF WHEAT AND CHICKPEA COMPOSITE FLOURS, Food Australia, 49(1), 1997, pp. 27-31
Authors:
IYER L
WHITINGTON P
ROY SK
RATAIN MJ
Citation: L. Iyer et al., GENETIC-BASIS FOR THE GLUCURONIDATION OF SN-38 - ROLE OF UGT-ASTERISK-1 ISOFORM, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 1-1
Authors:
IYER L",CHURCHMAN,DIMITRY,"REGINALD PW
Citation: Pw. Iyer L",churchman,dimitry,"reginald, MODE OF DELIVERY IN THE SUBSEQUENT PREGNANCY IN WOMEN WHO HAD AN INSTRUMENTAL VAGINAL DELIVERY IN THEIR FIRST PREGNANCY, British journal of obstetrics and gynaecology, 103(8), 1996, pp. 847-848
Authors:
CHANDRASEKHARAN M
LI GF
IYER L
HALL TC
Citation: M. Chandrasekharan et al., A COMPUTER-DERIVED MODEL FOR FACTOR INTERACTION IN PHASEOLIN EXPRESSION, Plant physiology, 111(2), 1996, pp. 113-113
Authors:
IYER L
IQBAL O
FAREED J
Citation: L. Iyer et al., RELEVANCE OF PHARMACOKINETICS WITH PHARMACODYNAMICS OF RECOMBINANT HIRUDIN IN DOGS, The FASEB journal, 9(4), 1995, pp. 688-688
Authors:
IYER L
IQBAL O
Citation: L. Iyer et O. Iqbal, CORRELATION BETWEEN PHARMACOKINETICS AND PHARMACODYNAMICS OF RECOMBINANT HIRUDIN IN DOGS, Thrombosis and haemostasis, 73(6), 1995, pp. 1455-1455
Authors:
IYER L
ADAM M
AMIRAL J
FAREED J
BERMES E
Citation: L. Iyer et al., DEVELOPMENT AND VALIDATION OF 2 ENZYME-LINKED-IMMUNOSORBENT-ASSAY (ELISA) METHODS FOR RECOMBINANT HIRUDIN, Seminars in thrombosis and hemostasis, 21(2), 1995, pp. 184-192
Authors:
IYER L
FAREED J
Citation: L. Iyer et J. Fareed, DETERMINATION OF SPECIFIC ACTIVITY OF RECOMBINANT HIRUDIN USING A THROMBIN TITRATION METHOD, Thrombosis research, 78(3), 1995, pp. 259-263
Authors:
OVSEPIAN A
IYER L
IQBAL O
FAREED J
Citation: A. Ovsepian et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF POLYETHYLENE-GLYCOL (PEG) COUPLED RECOMBINANT HIRUDIN IN PRIMATES, The FASEB journal, 8(4), 1994, pp. 10000094-10000094
Authors:
IYER L
ASSELMEIER S
IQBAL O
FAREED J
Citation: L. Iyer et al., EVALUATION OF RENAL-FUNCTION AND DISPOSITIONAL CHARACTERISTICS OF RECOMBINANT HIRUDIN IN RATS, The FASEB journal, 8(4), 1994, pp. 10000098-10000098
Authors:
IYER L
AMIRAL J
OVSEPIAN A
FAREED J
Citation: L. Iyer et al., INTEGRATION OF PHARMACODYNAMICS AND PHARMACOKINETICS OF RECOMBINANT HIRUDIN VARIANT-2 (RHV2-LYS-47) USING A MODIFIED RABBIT JUGULAR-VEIN STASIS THROMBOSIS MODEL AND A NOVEL ENZYME-LINKED-IMMUNOSORBENT-ASSAY (ELISA), Thrombosis and haemostasis, 69(6), 1993, pp. 1299-1299
Authors:
KOZA M
IYER L
KHENKINA Y
FASANELLA A
WALENGA JM
PIFARRE R
FAREED J
Citation: M. Koza et al., PROGRESSIVE ACCUMULATION OF R-HIRUDIN AFTER REPEATED SUBCUTANEOUS ADMINISTRATION - POTENTIAL IMPLICATIONS IN THE PROPHYLAXIS OF DVT, Thrombosis and haemostasis, 69(6), 1993, pp. 1301-1301
Authors:
ADAM M
IYER L
FAREED J
AMIRAL J
Citation: M. Adam et al., COMPETITIVE ENZYME-LINKED-IMMUNOSORBENT-ASSAY (ELISA) FOR MEASURING HIRUDINS IN BIOLOGICAL-FLUIDS, Thrombosis and haemostasis, 69(6), 1993, pp. 1304-1304
Authors:
IYER L
FAREED J
AMIRAL J
ADAM M
Citation: L. Iyer et al., APPLICATION OF A COMPETITIVE ENZYME-LINKED-IMMUNOSORBENT-ASSAY METHODIN THE STUDY OF PHARMACOKINETICS OF RECOMBINANT HIRUDIN IN ANIMAL-MODELS, Thrombosis and haemostasis, 69(6), 1993, pp. 1304-1304